Publications
26
Citations
844
Est. group size
—
Recurring co-author estimate
Active years
26
Publishing since 2001
Typically publishes in teams of ~17 · 0% small-team papers (≤3 authors) · across 13 venues
- A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies
npj Viruses · 2026
- BPS2025 - Structural analysis of human endogenous retrovirus K envelope protein
Biophysical Journal · 2025
- Human endogenous retrovirus K (HERV-K) envelope structures in pre- and post-fusion by Cryo-EM
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study
Transplant Infectious Disease · 2024
- A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodies
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Structure of the Inmazeb cocktail and resistance to Ebola virus escape
Cell Host & Microbe · 2023
- MTCH2 is a mitochondrial outer membrane protein insertase
Science · 2022
- Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
Cell · 2022
- Glycan shield of the ebolavirus envelope glycoprotein GP
Communications Biology · 2022
- Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo
PLoS neglected tropical diseases · 2022
- MTCH2 is a mitochondrial outer membrane protein insertase
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Glycan shield of the ebolavirus envelope glycoprotein GP
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Structure of the Inmazeb cocktail and resistance to escape against Ebola virus
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
Science · 2021
- Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent
Expert Review of Clinical Pharmacology · 2021
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Science×2
- JCI Insight×2
- JAMA×1
- Cell Host & Microbe×1
- Monica L. Husby
Medicine · Purdue University West Lafayette
- Balindile B. Motsa
Medicine · Purdue University West Lafayette
- Xiao Liu
Medicine · Purdue University West Lafayette
- Robert V. Stahelin
Medicine · Purdue University West Lafayette
- Souad Amiar
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile